EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology ... San Antonio, Texas. The data demonstrates the ability to ...
News
- Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To ... - Morningstar
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase ... - StreetInsider
The additional study results were presented in an oral presentation session at the 2025 San Antonio Breast Cancer Symposium (“SABCS”) today, Thursday, ...
- Roche's Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer - BioSpace
Roche presented these findings at the 2025 San Antonio Breast Cancer Symposium (SABCS). ... biotech and science. He can be reached at tristan ...
- Ed and Linda Whitacre contribute $7 million to support health research, engineering and ...
The University of Texas at San Antonio has received a $7 million gift commitment from longtime philanthropic supporter and former AT&T CEO Ed ...
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...
... San Antonio Breast Cancer Symposium. Share. SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology ...